Shohei Miyamoto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer.
Journal: Scientific reports
Published: October 12, 2022
Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3.
Journal: Anticancer research
Published: November 21, 2020
Width of the third ventricle as a highly-sensitive biomarker in chronic progressive neuro-Behçet's disease.
Journal: Journal of the neurological sciences
Published: June 02, 2020
A pilot study to establish human T-cell leukemia virus type 1 (HTLV-1) carrier model using common marmoset (Callithrix jacchus).
Journal: Journal of medical primatology
Published: August 16, 2019
Photocontrollable mononegaviruses.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 30, 2019
Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3.
Journal: Molecular therapy oncolytics
Published: December 19, 2018
KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.
Journal: Experimental hematology
Published: August 31, 2018
Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 24, 2018
Oncolytic coxsackievirus therapy as an immunostimulator.
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 09, 2017
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity.
Journal: Molecular therapy oncolytics
Published: February 22, 2016
TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
Journal: Cancer immunology research
Published: May 17, 2014
Last Updated: 09/26/2026